These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 31433233

  • 1. [Molecular cytogenetic analyses of patients with plasma cell myeloma in Tolna and Baranya counties in Hungary].
    Kosztolányi S, Horváth B, Hosnyánszki D, Kereskai L, Sziládi E, Jáksó P, Alizadeh H, Szuhai K, Alpár D, Kajtár B.
    Orv Hetil; 2019 Jun; 160(24):944-951. PubMed ID: 31433233
    [Abstract] [Full Text] [Related]

  • 2. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma.
    Alpar D, de Jong D, Holczer-Nagy Z, Kajtar B, Savola S, Jakso P, David M, Kosztolanyi S, Kereskai L, Pajor L, Szuhai K.
    Genes Chromosomes Cancer; 2013 Sep; 52(9):785-93. PubMed ID: 23720363
    [Abstract] [Full Text] [Related]

  • 3. Sequential analysis of chromosome aberrations in multiple myeloma during disease progression.
    Wu KL, Beverloo B, Velthuizen SJ, Sonneveld P.
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):280-5. PubMed ID: 17324335
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Cytogenetic characteristics of patients with multiple myeloma in China: analysis of 100 case].
    Deng SH, Xu Y, Wang YF, Mai YJ, Liu XP, Zhao YZ, Zou DH, Wang Y, Qiu LG.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 26; 87(24):1685-8. PubMed ID: 17825148
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cytogenetics of multiple myeloma.
    Trcić RL, Skelin IK, Sustercić D, Planinc-Peraica A, Ajduković R, Haris V, Kusec R, Begović D.
    Coll Antropol; 2010 Mar 26; 34(1):41-4. PubMed ID: 20432732
    [Abstract] [Full Text] [Related]

  • 8. Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India.
    Kadam Amare PS, Jain H, Nikalje S, Sengar M, Menon H, Inamdar N, Subramanian PG, Gujral S, Shet T, Epari S, Nair R.
    Indian J Med Res; 2016 Oct 26; 144(4):536-543. PubMed ID: 28256461
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The impact of clone size on the prognostic value of chromosome aberrations by fluorescence in situ hybridization in multiple myeloma.
    An G, Li Z, Tai YT, Acharya C, Li Q, Qin X, Yi S, Xu Y, Feng X, Li C, Zhao J, Shi L, Zang M, Deng S, Sui W, Hao M, Zou D, Zhao Y, Qi J, Cheng T, Ru K, Wang J, Anderson KC, Qiu L.
    Clin Cancer Res; 2015 May 01; 21(9):2148-56. PubMed ID: 25652456
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L, Li J, Xu W, Qiu H, Zhu Y, Zhang Y, Duan L, Qian S, Lu H.
    Exp Oncol; 2007 Jun 01; 29(2):116-20. PubMed ID: 17704743
    [Abstract] [Full Text] [Related]

  • 13. [Magnetic-activated cell sorting combined with multiplex ligation-dependent probe amplification for detecting molecular cytogenetic abnormalities in multiple myeloma].
    Lei M, Ma L, Kuang L, Pang Y, Wu J, Xiao Z, Li L.
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep 01; 32(9):1332-5. PubMed ID: 22985577
    [Abstract] [Full Text] [Related]

  • 14. Recurrent involvement of heterochromatic regions in multiple myeloma-a multicolor FISH study.
    Lange K, Gadzicki D, Schlegelberger B, Göhring G.
    Leuk Res; 2010 Aug 01; 34(8):1002-6. PubMed ID: 20022374
    [Abstract] [Full Text] [Related]

  • 15. Prognostic power of abnormal cytogenetics for multiple myeloma: a multicenter study in China.
    Lai YY, Huang XJ, Cai Z, Cao XS, Chen FP, Chen XQ, Chen BA, Fang MY, Feng JF, Fu WL, Guo HY, Hou M, Hou J, Hu Y, Hu XT, Hu XM, Huang LQ, Jin J, Li JY, Li J, Li W, Liang YM, Liu T, Liu QF, Liu YH, Mao P, Ouyang J, Qiu LG, Qiu L, Shao CK, Shi B, Song YP, Sun ZM, Wang QS, Wang C, Wang JM, Wang YS, Wang Z, Wu JB, Wu YX, Xia RX, Xue YQ, Yang BZ, Yang G, Yang ZL, Yu L, Yuan Z, Zhang S, Zhang Y, Zhao HG, Zhao L, Zhou DB, Zou SH, Zhu YF.
    Chin Med J (Engl); 2012 Aug 01; 125(15):2663-70. PubMed ID: 22931972
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
    Harrison CJ, Mazzullo H, Cheung KL, Gerrard G, Jalali GR, Mehta A, Osier DG, Orchard KH.
    Br J Haematol; 2003 Mar 01; 120(6):944-52. PubMed ID: 12648063
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
    Liu SY, Huang JW, Zhang J, Du HP, Jiang H, Li JY, Xue YQ.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec 01; 24(6):685-8. PubMed ID: 18067084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.